Autel launches new MaxiCharger DC Compact worldwide
17.1.2023 14:57:00 EET | Business Wire | Press release
Autel is today announcing the launch of an innovative electric vehicle DC charger, the MaxiCharger DC Compact, providing up to 40kW of DC power for the U.S. version and 47kW of power for the European version. The MaxiCharger DC Compact comes with two charging cables, allowing two vehicles to charge simultaneously with dynamic power distribution.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230117005624/en/
The MaxiCharger DC Compact comes with options like a credit card reader and a pedestal. (Photo: Business Wire)
The MaxiCharger DC Compact is sleek and compact with a 21.5-inch LCD touchscreen for user-friendly interaction and advertising capability. It can be hung on a wall, placed on a pedestal, or set on wheels for ultimate portability. The MaxiCharger DC Compact is perfect for businesses wanting to provide their customers with a quick top-up charge option without breaking the bank on a DC Fast charger. It is also an excellent option for commercial fleets that need a slower DC charge for their fleet vehicles to charge overnight.
“This is an exciting launch for Autel as we establish ourselves as the worldwide leader in electric vehicle charging,” said Kelvin Cao, Vice President of Global Marketing at Autel. “The MaxiCharger DC Compact is small in size but a powerful addition to our growing portfolio of EV chargers, and a great fit for businesses needing an affordable, yet fast EV charger.”
Elevated Efficiency with Dual Ports
The MaxiCharger DC Compact is designed to increase charging efficiency, providing up to 47kW of power with dual-ports. It can charge 2 vehicles simultaneously, sharing power dynamically between the two vehicles. A 30 minute charge equates to about 130 km of range, saving on charging time.
Smart Advertising and Communication Platform
Powered by the smart operating system, Android 10, with a user-friendly 21.5-inch LCD touchscreen and enhanced advertising placement capability, the MaxiCharger DC Compact communicates with, engages and attracts customers, generating new revenue streams.
Compatibility
The MaxiCharger DC Compact is OCPP1.6 capable. It is compatible with CCS1, CCS2 and CHAdeMO charging cables, depending on operator and regional needs. With the Autel Charge app, RFID cards, and credit card capability, the MaxiCharger DC Compact offers convenient ways for end users to pay for and begin their charging sessions. It offers 4G, Wi-Fi, and ethernet connectivity options and supports regular over-the-air software updates with an internet connection.
Cloud Platform
The MaxiCharger DC Compact is powered on the backend using Autel’s smart charge cloud platform. The cloud platform helps charge point operators view, monitor, and analyze charger data in real-time. Operators can also view revenue and user data, and set advertisements all from the cloud platform. Autel’s cloud management platform allows all operators to efficiently and conveniently manage their chargers in one easy-to-use interface.
Become a Dealer
If you are interested in becoming a dealer for the MaxiCharger DC Compact and for all of the MaxiCharger series of EV chargers, head over to the Autel website and fill out our dealer form. If you are interested in purchasing a MaxiCharger DC Compact, contact your local Autel sales representative or contact us below.
About Autel
Autel designs, engineers, and manufactures some of the most advanced products for residential and commercial users, offering hardware, software, apps, and cloud-based solutions to cover almost every use case and application.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230117005624/en/
Contact information
Michael Madden
marketing@autel.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202630.8.2026 00:54:00 EEST | Press release
Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon company, in strategic partnership with the Emirates Falconers’ Club, at ADNEC Centre Abu Dhabi. The exhibition runs until 6 September. The falcon, owned
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 01:40:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the total amount of blood in the body. Maintaining controlled hematocrit levels below 45% is the primary treatment goal in PV.1 “For patients living with PV, uncontrolled hematocrit can have serious consequences, including an elevated risk of life-threatening thrombotic events," said Andrew T. Kuykendall, M.D., VERIFY lead investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “Curre
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 17:00:00 EEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 16:34:00 EEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 12:00:00 EEST | Press release
Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely with healthcare authorities and other stakeholders to support timely access for people with Parkinson’s disease who continue to experience moderate to severe motor fluctuations despite current oral therapies. Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. Despite availab
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom